Nivolumab-induced Diaphragm Dysfunction: A Case Report.

Indian J Crit Care Med

Department of Intensive Care Medicine, Amsterdam University Medical Centers, Amsterdam, North Holland, Netherlands.

Published: February 2023

Unlabelled: Nivolumab is increasingly used in the treatment of melanoma. However, its use is associated with potentially severe side effects and every organ system can be affected. A case is presented where nivolumab therapy resulted in severe diaphragm dysfunction. With nivolumab's increased use, these types of complications may become more common and every clinician should be alerted to its potential presence when a patient on nivolumab treatment presents with dyspnea. Ultrasound is a readily available method to assess for diaphragm dysfunction.

How To Cite This Article: Schouwenburg JJ. Nivolumab-induced Diaphragm Dysfunction: A Case Report. Indian J Crit Care Med 2023;27(2):147-148.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973063PMC
http://dx.doi.org/10.5005/jp-journals-10071-24178DOI Listing

Publication Analysis

Top Keywords

diaphragm dysfunction
12
nivolumab-induced diaphragm
8
dysfunction case
8
case report
8
report unlabelled
4
unlabelled nivolumab
4
nivolumab increasingly
4
increasingly treatment
4
treatment melanoma
4
melanoma associated
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!